KILLING THE PAIN

understanding the issues relating to Heroin, Fentanyl, Prescription and OTC opiate painkillers


Duration: 1 Day

Times: 9.30 am - 4.15 pm

DANOS Units: AA1, AB2, HSC335, HSC395, HSC33


Course Overview

This one day course provides a comprehensive overview of current issues relating to the use and abuse of both legal and illegal opiate painkillers in the UK. Using the latest medical and social research the course examines the changing patterns of heroin and synthetic opioid use, physical and mental health issues, as well as informing delegates on recommended options for helping clients who are dependent on any type of painkiller including Over The Counter Painkillers such as Solpadeine.

The course is suitable for all staff who require up to date information and advice on current issues relating to opiate use and how to work with clients who may be using them.

Learning Objectives

Course materials

Each participant will receive a course information booklet, drugs education resources, a DANOS linked Certificate of Attendance and free subscription to the 'Drugs Now' e-zine.

Course duration

The length of the course is usually 9.30 – 4.15 p.m. but for those booking the course for in-house staff training the timings can be adapted to suit your particular needs or requirements.

The 'Killing The Pain' course helps delegates develop their knowledge, skills and competence in the following DANOS units: AA1, AB2, HSC335, HSC395, HSC33


Programme Outline


9.30am - 4.15pm

AM

What are opiates and how are they produced?

How opiate use can lead to addiction: key signs of opiate dependency

Heroin: the changing issues with street heroin

Naloxone: how it works and why the Naloxone Programme is being expanded

Prescription opiates: their increased use and abuse LUNCH


PM

OTC painkillers: codeine addiction and its hidden dangers

Online access to new synthetic opioids: acetyl fentanyl, illicitly produced Oxycontin, etc

Reducing the Harm – important tips for heroin and other illicit opiates

Helping users quit or reduce their use – overview of practical tools for professionals

Drugs Now